INSPIRATION HEALTHCARE GROUP PLC

Regulatory Filings • May 17, 2021

National Storage Mechanism | Additional information

RNS Number : 7508Y

Inspiration Healthcare Group PLC

17 May 2021

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

£1.25m Ventilator Order received from China

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, is pleased to announce that its wholly owned subsidiary SLE Ltd, which was acquired in July 2020, has received an order worth over £1.25 million to supply ventilators to China which have been sold through its Chinese distributor and which are to be delivered within the next three months.

This new order follows on from the regulatory approval received from the Chinese National Medical Products Administration (NMPA) announced on 21 April 2021 for SLE's top of the range SLE6000 model and is in addition to the order announced at that time, whose value totalled approximately £250,000.

Neil Campbell, Chief Executive Officer, commented:

"We are delighted to be making such strong progress in China within such a short space of time since receiving regulatory approval and this new order certainly helps to strengthen the outlook for the Group going forward. As I have stated previously, China represents a significant growth opportunity and, whilst this order does not change our expected outcome for the year, it is another boost to our confidence as we continue to develop Inspiration Healthcare's position in this important market."

Enquiries:

Inspiration Healthcare Group plc Neil Campbell, Chief Executive Officer Jon Ballard, Chief Financial Officer	Tel: 01455 840555
Nominated Adviser & Broker Cenkos Securities plc Mark Connelly Stephen Keys	Tel: 0207 397 8900
Cadogan PR                                                                                          Alex Walters alex.walters@cadoganpr.com	Tel: 07771 713608

About Inspiration Healthcare Group

www.inspirationhealthcaregroup.plc.uk

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.

The Group currently consists of three companies: Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal intensive care and operating theatre equipment around the work through a network of distributors into over 75 countries.  Products range from highly sophisticated capital equipment through to single use disposables all that can help improve outcomes of extremely sick patients.

In the UK and Ireland the Group offers direct sales for most of its products supported by Technical Service offering on site and return to base repair and maintenance along with 24/7 emergency hire of equipment and long term lease arrangements for its own brand products.  The Group also acts as a distributor for 3rd party companies that wish to access the NHS using the Group's sales and service expertise and knowledge of the NHS

The Group invests in growth through Research and Development holding numerous patents on its technology and has strong links with academic Key Opinion Leaders around the world and supports clinical research in the field of neonatal intensive care.

Further information on Inspiration Healthcare Group plc can be seen at  www.inspirationhealthcaregroup.plc.uk 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUVSNRAKUVARR